Related Experiment Video
Updated: Jun 26, 2026

09:33
An Anaerobic Biosensor Assay for the Detection of Mercury and Cadmium
Published on: December 17, 2018
A case report of elevated blood cadmium
Christopher J Martin1, James M Antonini, Brent C Doney
1Institute of Occupational and Environmental Health, School of Medicine, West Virginia University, Morgantown, WV 26506-9190, USA. cmartin@hsc.wvu.edu
Occupational Medicine (Oxford, England)
|January 17, 2009
Summary
Cigarette brand significantly impacts cadmium levels. Switching to a higher cadmium tobacco brand elevated a worker's blood cadmium, while returning to the original brand lowered it, highlighting smoking as a key exposure source.
Area of Science:
- Environmental Health
- Occupational Medicine
- Toxicology
Background:
- Occupational exposure to cadmium is a concern in industries like paint manufacturing.
- Routine biological monitoring is crucial for assessing worker exposure to heavy metals.
- Cigarette smoking is a known non-occupational source of cadmium exposure.
Observation:
- A paint technician presented with elevated whole-blood cadmium levels exceeding occupational safety limits.
- Despite reassignment from direct cadmium exposure, blood cadmium remained elevated.
- A recent change in cigarette brand coincided with the elevated cadmium levels.
Findings:
- Analysis revealed the new cigarette brand contained 1.5 times more cadmium than the original brand.
- Switching back to the original cigarette brand and reducing consumption led to a significant decrease in blood cadmium.
- Blood cadmium levels fluctuated in correlation with changes in cigarette brand and consumption.
Implications:
- Variations in cigarette tobacco cadmium content can significantly influence an individual's overall cadmium burden.
- Healthcare providers should consider cigarette brand as a critical factor in assessing cadmium exposure.
- Workplace monitoring programs should account for lifestyle factors like smoking habits and brand choice.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...